Based on the 2023 forecasted data, Japan leads with sales of $6.28 billion, followed by South Korea ($3.65 billion) and Greece ($1.62 billion). Countries like Iceland, Costa Rica, and Slovenia show comparatively lower sales. Year-on-year variations indicate positive growth trends, notably Iceland at 12.76%, Belgium at 11.28%, and Slovenia at 9.95%. Greece, on the other hand, experienced a decline of -3.47%. Five-year CAGR will offer deeper insight into the growth trajectories.
Future trends to watch include emerging markets' increasing contributions, advancements in biotechnology driving new product developments, and geopolitical events potentially impacting healthcare budgets. Additionally, demographic shifts and aging populations in developed countries will likely continue to drive demand for blood and blood-forming organ medicines.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 6,280 | 2023 | +1.86% | +6.85% | View data |
| 2 | 2 South Korea | 3,650 | 2023 | +5.81% | +6.29% | View data |
| 3 | 3 Greece | 1,620 | 2023 | +5.5% | -3.47% | View data |
| 4 | 4 Belgium | 1,360 | 2023 | +9.08% | +11.28% | View data |
| 5 | 5 Australia | 810.2 | 2023 | +6.87% | +7.86% | View data |
| 6 | 6 Sweden | 727.6 | 2023 | +5.43% | +6.8% | View data |
| 7 | 7 Denmark | 423.9 | 2023 | +5.06% | +5.75% | View data |
| 8 | 8 Norway | 298 | 2023 | +3.83% | +2.62% | View data |
| 9 | 9 Mexico | 208.2 | 2023 | +0.51% | +7.59% | View data |
| 10 | 10 Slovenia | 154.1 | 2023 | +7.39% | +9.95% | View data |
